EP0909172A4 - Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,s)-glycopyrrolate - Google Patents

Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,s)-glycopyrrolate

Info

Publication number
EP0909172A4
EP0909172A4 EP97932348A EP97932348A EP0909172A4 EP 0909172 A4 EP0909172 A4 EP 0909172A4 EP 97932348 A EP97932348 A EP 97932348A EP 97932348 A EP97932348 A EP 97932348A EP 0909172 A4 EP0909172 A4 EP 0909172A4
Authority
EP
European Patent Office
Prior art keywords
glycopyrrolate
compositions
methods
urinary incontinence
enantiomerically enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97932348A
Other languages
German (de)
French (fr)
Other versions
EP0909172A1 (en
Inventor
Vincent L Fabiano
John R Mccullough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0909172A1 publication Critical patent/EP0909172A1/en
Publication of EP0909172A4 publication Critical patent/EP0909172A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP97932348A 1996-07-01 1997-06-27 Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,s)-glycopyrrolate Withdrawn EP0909172A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2094896P 1996-07-01 1996-07-01
US20948P 1996-07-01
PCT/US1997/011257 WO1998000132A1 (en) 1996-07-01 1997-06-27 Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,s)-glycopyrrolate

Publications (2)

Publication Number Publication Date
EP0909172A1 EP0909172A1 (en) 1999-04-21
EP0909172A4 true EP0909172A4 (en) 1999-06-09

Family

ID=21801459

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97932348A Withdrawn EP0909172A4 (en) 1996-07-01 1997-06-27 Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,s)-glycopyrrolate

Country Status (2)

Country Link
EP (1) EP0909172A4 (en)
WO (1) WO1998000132A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613795B2 (en) 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
PL195520B1 (en) 1996-11-11 2007-09-28 Meda Pharma Gmbh & Co Kg Enatiomerically pure basic arylocycloalkyl hydroxycarboxylic esters, method obtaining them and their application a therapeutic agents
CA2492121A1 (en) 2002-07-08 2004-01-15 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
AU2002347552A1 (en) 2002-12-23 2004-07-14 Ranbaxy Laboratories Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7517905B2 (en) 2003-04-09 2009-04-14 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EP1680098A4 (en) * 2003-11-04 2012-06-13 Supernus Pharmaceuticals Inc Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
EP3473615B1 (en) 2013-02-28 2022-01-19 Journey Medical Corporation Glycopyrrolate salts
JP7161466B2 (en) 2016-08-02 2022-10-26 ジャーニー メディカル コーポレーション Methods for making and using glycopyrronium compounds
CN109044965A (en) * 2018-10-17 2018-12-21 广州大光制药有限公司 The medical composite for eye and medical usage of glycopyrronium bromide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DANIEL W. ARMSTRONG ET AL.: "Separation of drug stereoisomers by formation of beta-cyclodextrin inclusion complexes", SCIENCE, vol. 232, no. 4754 part 1, 1986, pages 1132 - 1135, XP002099198 *
See also references of WO9800132A1 *

Also Published As

Publication number Publication date
WO1998000132A1 (en) 1998-01-08
EP0909172A1 (en) 1999-04-21

Similar Documents

Publication Publication Date Title
PL330752A1 (en) Pharmaceutical agent for treating urinary incontinence
AU2593900A (en) Composition and method for treating glaucoma
HK1031174A1 (en) Compositions and methods for treating diabetes
AU4988997A (en) Compositions and methods for treating bone deficit conditions
ZA966838B (en) Method and composition for treating asthma.
AU3828397A (en) Apparatus with valve for treating incontinence
ZA949509B (en) A method and composition for treating biopsy sounds.
AU6872498A (en) Method and composition for skin treatment
AU2113295A (en) Novel compositions and methods for water treatment
AU9214398A (en) Compositions and methods for treating water
ZA978427B (en) Method of treating urinary incontinence
EP0909172A4 (en) Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,s)-glycopyrrolate
EP0909163A4 (en) Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,r)-glycopyrrolate
EP0920419A4 (en) Compounds, compositions and methods for treating influenza
AU3401199A (en) Method and composition for treating psoriasis
AU3909897A (en) Apparatus for treating incontinence in females
AU5594398A (en) Methods and compositions for preventing and treating bone loss
EP0759745A4 (en) Method and composition for increasing calcium uptake
GB9420616D0 (en) Method, compositions and use
EP0909170A4 (en) Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-tridihexethyl
AU2705195A (en) Incontinence treatment
AU5791698A (en) Methods and compositions for preventing and treating bone loss
EP0874636A4 (en) Tea, kit and method for treating hemorrhoids
EP0938313A4 (en) Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-clidinium
EP0957916A4 (en) Methods and compositions for treating urinary incontinence using enantiomerically enriched (r)-clidinium

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990423

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000308

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20011030